Attention Deficit Hyperactivity Disorder (ADHD) News and Research

RSS

Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral).

Genetic risk for developing psychiatric disorders or cognitive traits manifest in brain structure from childhood

There is only scant scientific evidence available on whether the genetic risk for developing specific psychiatric disorders or cognitive traits is manifest in brain structure from childhood and, to date, studies have focused primarily on adult populations. The question remains unanswered.

25 Jan 2019

Mutant mice administered with cocaine failed to exhibit hyperactivity, shows study

Cocaine is a highly addictive psychostimulant that induces complex molecular, cellular and behavioral responses. Despite various approaches and years of pre-clinical studies, effective, mechanism-based therapies to assist with cocaine misuse and dependence are still sorely lacking.

16 Jan 2019

Study explores link between prenatal exposure to antiepileptic drugs and children's ADHD risk

This study examined whether prenatal exposure to valproate and other antiepileptic drugs was associated with increased risk of attention-deficit/hyperactivity disorder (ADHD) in children.

4 Jan 2019

Commonly prescribed ADHD drug unlikely to increase cardiovascular risks in children

With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder, the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike.

3 Jan 2019

Researchers evaluate digital medicine tool to treat children with autism and co-occurring ADHD

Researchers at Children's Hospital of Philadelphia evaluated a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder and co-occurring attention/deficit-hyperactivity disorder.

3 Jan 2019

FDA warns against use of jewelry to relieve teething pain in children

Today, the U.S. Food and Drug Administration alerted parents, caregivers and health care providers to the safety risks that jewelry used for relieving teething pain pose for children.

21 Dec 2018

Researchers discover first common genetic risk factors associated with ADHD

A global team of researchers has found the first common genetic risk factors associated with attention deficit hyperactivity disorder, a complex condition affecting around 1 in 20 children.

27 Nov 2018

International study of ADHD at genomic scale

An international study, focused on the analysis of the genome of more than 50,000 people worldwide, has identified twelve specific fragments of DNA related to the vulnerability of the attention deficit hyperactivity disorder.

26 Nov 2018

First probabilistic atlas of thalamus nuclei to better understand the brain

A multidisciplinary study led by BCBL, a Basque research center, opens the door to the investigation of the structure and functions of human thalamic nuclei and their involvement in Alzheimer's, dyslexia, epilepsy, Huntington's and schizophrenia.

20 Nov 2018

Kessler Foundation fellow receives award to explore behavioral patterns in children with ADHD

Joman Y. Natsheh, MD, PhD, postdoctoral fellow in Pediatric Neuroscience and Neuropsychology Research at Kessler Foundation, has received a $13,500 pilot award from Texas Woman's University, Woodcock Institute for the Advancement of Neurocognitive Research and Applied Practice.

24 Oct 2018

Green filters increase reading speed for children with dyslexia

Reading, one of the most difficult activities for children with dyslexia, can be improved by the use of green filters.

19 Oct 2018

Sub-concussive impacts not associated with decline in neurocognitive function

In an investigation of head impact burden and change in neurocognitive function during a season of youth football, researchers find that sub-concussive impacts are not correlated with worsening performance in neurocognitive function.

15 Oct 2018

Prenatal fluoride exposure linked to ADHD symptoms in children

Higher levels of urinary fluoride during pregnancy are associated with more ADHD-like symptoms in school-age children, according to University of Toronto and York University researchers.

11 Oct 2018

New review points to statistically small link between children's screen media use and ADHD

There is a statistically small relationship between children's screen media use and ADHD-related behaviors. This is the finding of an extensive literature review on this subject carried out by researchers from the UvA's Center for research on Children, Adolescents and the Media.

4 Oct 2018

Scientists use machine learning to better predict learning difficulties in children

Scientists using machine learning - a type of artificial intelligence - with data from hundreds of children who struggle at school, identified clusters of learning difficulties which did not match the previous diagnosis the children had been given.

30 Sep 2018

New study aims to identify babies at higher risk of autism and ADHD

London researchers are set to start a three year study aiming to identify babies at higher than average risk of autism spectrum conditions and attention deficit hyperactivity disorder.

27 Sep 2018

Robert Koch Institute publishes new data on allergies, mental health problems, and accident injuries

The Robert Koch Institute has published new data from the German Health Interview and Examination Survey for Children and Adolescents on allergies, mental health problems and accident injuries.

19 Sep 2018

ADHD patients have increased risk of developing Parkinson's and other similar diseases

While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder, the long-term health effects of having ADHD and of common ADHD medications remains understudied.

12 Sep 2018

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.

3 Sep 2018

Common ADHD drug may cause adverse psychotic side effects

In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder and narcolepsy.

22 Aug 2018